FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the field of medicine and pharmaceuticals. The first object is an emulsion of perfluorocarbon compounds for medical use as a base for blood substitutes, including the fast-removing component of perfluorodecalin, a mixed perfluorocarbon additive and phospholipids, characterized in that it includes phospholipids in liposomal form, which acts as an emulsifier, and prepared by homogenization under pressure in the range of 60-120 atm in an aqueous-salt medium, and the perfluorocarbon additive is a mixture of perfluorooctyl bromide and perfluorotropropylamine. The second object is a method for producing an emulsion of perfluorocarbons, including obtaining a liposomal emulsifying form of phospholipids by homogenization under pressure within the range of 60-120 atm in a water-salt medium, followed by heat sterilization in the temperature range of 60-95°C, homogenization under pressure of perfluorocarbon compounds in a liposomal emulsifying form of phospholipids and heat sterilization of the finished emulsion.
EFFECT: stability of the emulsion for two years of storage at +4°C while maintaining the structure of the particles due to the use of phospholipids in liposomal form as an emulsifier.
14 cl, 8 dwg, 12 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
EMULSION OF PERFLUOROORGANIC COMPOUNDS OF MEDICINAL INDICATION AND METHOD FOR ITS OBTAINING | 2004 |
|
RU2259819C1 |
METHOD OF TARGETED TRANSPORT OF BIOLOGICALLY ACTIVE SUBSTANCES AND APPLICATION OF STEM CELLS FOR TARGETED TRANSPORT | 2009 |
|
RU2426785C1 |
METHOD OF TREATING SOLID MALIGNANT GROWTHS AND THEIR METASTASES | 2010 |
|
RU2437692C2 |
MEDICAL EMULSION OF PERFLUORORGANIC COMPOUNDS, METHOD OF PREPARATION AND METHOD OF APPLICATION | 2006 |
|
RU2393849C2 |
EMULSION OF PERFLUOROORGANIC COMPOUND EXHIBITING GAS-TRANSPORT PROPERTY | 1993 |
|
RU2088217C1 |
EMULSION OF PERFLUOROORGANIC COMPOUNDS WITH GAS-TRANSPORTING PROPERTY | 2003 |
|
RU2240108C1 |
EMULSION OF PERFLUORO-GANIC COMPOUNDS WITH INCREASED OXYGEN CAPACITY | 2022 |
|
RU2803466C2 |
1,2-BIS(PERFLUORO-tert-BUTOXY)ETHANE AS A CONTRAST FOR F NUCLEUS MAGNETIC RESONANCE IMAGING | 2022 |
|
RU2795915C1 |
PHARMACEUTICAL COMPOSITION OF STERILE EMULSION OF ORGANOPERFLUORINE COMPOUNDS AND POLYELECTROLYTES AND METHOD OF ITS OBTAINING | 2022 |
|
RU2811867C1 |
METHOD OF PHOTODYNAMIC THERAPY OF SUBJECTS WITH MALIGNANT TUMOURS | 2010 |
|
RU2440158C2 |
Authors
Dates
2021-03-23—Published
2019-04-12—Filed